Recombinant Human Prostatic Acid Phosphatase / ACPP Protein (His tag) 20µg

Size

20µg

Catalog No

PKSH031335-20µg

Price

626€

Synonym

5'-NT;ACP-3;ACP3;PAP

Activity

Measured by its ability to cleave a substrate, pNitrophenyl phosphate (pNPP). The specific activity is >100,000 pmol/min/μg.

Sequence

Met 1-Lys 382

Recombinant Human Prostatic Acid Phosphatase / ACPP Protein (His tag) 20µg

Fusion tag

C-His

Accession

NP_001127666.1

Expressed Host

HEK293 Cells

Recombinant Human Prostatic Acid Phosphatase / ACPP Protein (His tag) 20µg

Shipping

In general, recombinant proteins are provided as lyophilized powder which are shipped at ambient temperature.Bulk packages of recombinant proteins are provided as frozen liquid. They are shipped out with blue ice unless customers require otherwise.

Purity

>97 % as determined by SDS-PAGE

Endotoxin

<1.0 EU per µg as determined by the LAL method

Recombinant Human Prostatic Acid Phosphatase / ACPP Protein (His tag) 20µg

Stability and Storage

Samples are stable for up to twelve months from date of receipt at -70℃.Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.

Mol Mass

42 kDa

AP Mol Mass

45-55 kDa

Recombinant Human Prostatic Acid Phosphatase / ACPP Protein (His tag) 20µg

Formulation

Lyophilized from sterile PBS, pH 7.4

Reconstitution

Please refer to it for detailed information.

Background

Prostatic acid phosphatase (PAP, or ACPP), also known as prostatic specific acid phosphatase (PSAP), is an enzyme produced by the prostate. As a non-specific phosphomonoesterase, Prostatic acid phosphatase synthetized and secreted into seminal plasma under androgenic control. The enzyme is a dimer of molecular weight around 100 kDa. Prostatic acid phosphatase is a clinically important protein for its relevance as a biomarker of prostate carcinoma. Furthermore, it has a potential role in fertilization. The major action of PAP is to dephosphorylate macromolecules with the help of catalytic residues (His(12) and Asp(258)) that are located in the cleft between two domains. Cellular prostatic acid phosphatase (cPAcP), an authentic tyrosine phosphatase, is proposed to function as a negative growth regulator of prostate cancer (PCa) cells in part through its dephosphorylation of ErbB-2. cPAcP functions as a neutral protein tyrosine phosphatase (PTP) in prostate cancer cells and dephosphorylates HER-2/ErbB-2/Neu (HER-2: human epidermal growth factor receptor-2) at the phosphotyrosine (p-Tyr) residues. Injection of the secretory isoform of PAP has potent antinociceptive effects in mouse models of chronic pain. This enzyme exhibits ecto-5'-nucleotidase activity, is widely distributed, and implicated in the formation of chronic pain. Additionally, PAP could be a target molecule in specific immunotherapy for patients with nonprostate adenocarcinomas including colon and gastric cancers.

Recombinant Human Prostatic Acid Phosphatase / ACPP Protein (His tag) 20µg

Conjugation

histidine

Properties

Human proteins, cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies. Modern humans (Homo sapiens, primarily ssp. Homo sapiens sapiens). Depending on the epitopes used human ELISA kits can be cross reactive to many other species. Mainly analyzed are human serum, plasma, urine, saliva, human cell culture supernatants and biological samples.

Source

Recombinants or rec. proteins

Recombinant Human Prostatic Acid Phosphatase / ACPP Protein (His tag) 20µg

Group

recombinants

Recombinant Human Prostatic Acid Phosphatase / ACPP Protein (His tag) 20µg